Spike glycoprotein

The S protein, a large trimeric transmembrane glycoprotein, forms a distinctive crown-like structure on the virus's surface, earning its name from its unique shape characterized by prominent spikes. This protein comprises two functional subunits: S1 and S2. The S1 subunit features two essential structural domains, namely the Receptor Binding Domain (RBD) and the N-terminal Domain (NTD). The S2 subunit, on the other hand, comprises three domains: the Heptad Repeat (HR), the Central Helix (CH), and the Connector Domain (CD). The primary function of the S protein is to facilitate the entry and infection of viruses into host cells. This is achieved through its interaction with specific receptors on the surface of host cells. In the case of SARS-CoV-2, the S protein binds to the ACE2 receptor present on human cells, initiating the infection process. The S1 subunit is responsible for recognizing and binding to receptors on the host cell surface, while the S2 subunit mediates the fusion of the virus envelope with the host cell membrane, enabling the injection of the virus's genetic material into the cell and achieving infection. The signaling pathway of the S protein primarily involves its interaction with host cell receptors and the membrane fusion process. When the RBD region of the S protein binds to the ACE2 receptor on the host cell surface, it triggers a series of intracellular signaling events. These events may involve various intracellular molecules and pathways, ultimately leading to the fusion of the virus envelope with the host cell membrane, the release of the virus's genetic material, and the completion of the infection process. A comprehensive understanding of the S protein's role in the viral infection process is crucial for developing vaccines and antiviral drugs targeting coronaviruses. This knowledge provides vital information for designing effective therapeutic strategies against these pathogens.

Popular Product:

● Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S), partial (Active)

Validated Data

SDS

(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Predicted band size: 51.1 kDa
Observed band size: 66 kDa due to glycosylation

ELISA

Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD at 2 μg/ml can bind Biotinylated Anti-SARS-CoV-2-S Antibody (CSB-RA33245D1GMY), the EC₅₀ of SARS-CoV-2-S1-RBD protein is 106.2-131.2 ng/ml.

ELISA

Measured by its binding ability in a functional ELISA. Immobilized human ACE2 (CSB-MP866317HU) at 2 μg/ml can bind SARS-CoV-2-S1-RBD, the EC₅₀ of SARS-CoV-2-S1-RBD protein is 8.363-12.82 ng/ml.

● Recombinant Human SARS coronavirus Spike glycoprotein (S), partial (Active)

Validated Data

SDS

(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.

ELISA

Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV S-RBD at 2 μg/ml can bind Paguma larvata ACE2 (CSB-MP684964PAL), the EC₅₀ is 5.056-7.559 ng/ml.

ELISA

Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV S-RBD at 5 μg/ml can bind human ACE2 (CSB-MP866317HU), the EC₅₀ is 7.941-10.49 ng/ml.